Kenneth Londoner

Kenneth L.
Londoner founded Red Coat Capital Management LLC in 1997, where he worked as Chief Executive Officer & General Partner in 2005, Carolina Linkages, Inc. in 2005, where he worked as Executive Vice President, Safe Ports LLC in 2005, where he worked as Executive Vice President, Safe-Ports Holdings LLC in 2005, where he is working as Director from 2005, and BioSig Technologies, Inc. in 2009, where he worked as Executive Chairman & Chief Executive Officer from 2017 to 2024.
Mr. Londoner also currently works at NeuroClear Technologies, Inc., as Chairman, President & Chief Executive Officer from 2019, Viralclear Pharmaceuticals, Inc., as Chairman from 2020, and Endicott Management Partners LLC, as Managing Partner from 2010.
Mr. Londoner also formerly worked at Viralclear Pharmaceuticals, Inc., as Chairman, President & Chief Executive Officer from 2019 to 2020, chatAND, Inc., as Director from 2012 to 2015, Aduromed Industries, Inc., as Director from 2008 to 2009, MedClean Technologies, Inc., as Director from 2008 to 2010, Alliqua BioMedical, Inc., as Independent Director from 2012 to 2014, Seligman Capital Fund, Inc., as Co-Manager & Investment Officer from 1991 to 1997, Seligman Growth Fund, Inc., as Co-Manager & Investment Officer from 1991 to 1997, State Street Bank & Trust Co., as Accountant-Mutual Fund from 1989 to 2013, JWS Trust Co., as Vice President & Investment Officer in 1997, and NewCardio, Inc., as Executive Vice President-Finance from 2007 to 2009.
Mr. Londoner received his undergraduate degree in 1989 from Lafayette College and Masters Business Admin degree in 1994 from The Leonard N Stern School of Business.